1 Department of Medicine/Nephrology, Stanford University, Palo Alto, CA.
2 Geriatric Research Education and Clinical Center, VA Palo Alto Health Care System, Palo Alto, CA.
Received 14 April 2022. Revision received 20 June 2022.
Accepted 3 July 2022.
L.E.H., J.C.T., and J.S.M. all participated in writing this article, as well as editing and approving the submitted version.
J.S.M. has honoraria from One Lambda, Inc, and has a family member who is employed by and has an equity interest in Genentech/Roche. J.S.M. is also a member of the scientific advisory board for Qihan. J.C.T. has a family member who is employed by and has an equity interest in Genentech/Roche. The other author declares no conflicts of interest.
This work was supported by awards to J.S.M. from the Veterans Administration (1I01CX001971), J.C.T. from the John M. Sobrato Gift Fund, and L.E.H. from the National Institutes of Health (K01 1K01DK123196).
Correspondence: Jonathan Maltzman, MD, PhD, Geriatric Research Education and Clinical Center, VA Palo Alto Health Care System, 3801 Miranda Ave, Building 710, Room 202C, Palo Alto, CA 94304. ([email protected]).
